Board of Directors and management

Corporate bodies

• Alberto Azzolini

  Chairman of the Board and Managing Director

  sole signature · Italian national

  azzolini@pharmeq.ch+39 331 302 3485

• Dr. Günther Weber

  Member of the Board of Directors

  sole signature · German national

By declaration of 28 April 2023 the company waived a limited statutory examination (opting-out under art. 727a para. 2 CO).

Policies governing corporate bodies

Two documents in the policy register address the Board of Directors and Executive Management directly.

• PQ-COM-04Conflicts of Interest PolicyWhen a conflict of interest exists, how it is reported and how it is to be handled in resolutions.
• PQ-COM-05Outside Activities Policy for the Board of Directors and Executive ManagementOutside activities and shareholdings of members of the corporate bodies are subject to approval and disclosure.